Ticker LaunchLondon · Main Market · IPO
Genflow Biosciences Plc
Genflow Biosciences Plc was admitted to Main Market on Jan 17, 2022, raising £3.7M at 8p per share. Its market capitalization at admission was about £23.4M. Brokers: Clear Capital Markets Ltd.
Genflow Biosciences Plc is a UK biotechnology company focused on longevity and the development of therapies to counteract ageing and age-related diseases.
- Type
- IPO
- Market
- Main Market · Standard
- Admitted
- Jan 17, 2022
- Offer price
- 8p
- Raised
- £3.7M
- Market cap at admission
- £23.4M
- Brokers
- Clear Capital Markets Ltd
- Sector
- Biotech & pharma
- Country
- United Kingdom
More on this listing for subscribers
- Intention-to-float date
- New money versus sale shares
- Source announcements
Every record in the database also has its full filing timeline, a daily-updated calendar, watchlist alerts and Excel export.
Then $99/month or $999/year. Cancel anytime.
Sources
From company announcements filed with the FCA's National Storage Mechanism. Subscribers see the list of announcements for each listing.
Other London listings around the same time
- Hercules Site Services plcAIM · Feb 4, 2022
- ACP Energy PLCMain Market · Jan 28, 2022
- Electric Guitar PLCMain Market · Jan 11, 2022
- Graft Polymer (UK) PlcMain Market · Jan 6, 2022
- Facilities by ADF plcAIM · Jan 5, 2022
- ATOME Energy PLCAIM · Dec 30, 2021